In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Pharmion (in-licenses hematology and oncology drugs) raised $65mm in a mezzanine financing round led by Nomura International. Return investors Domain Associates, Versant Ventures, Aberdare Ventures, Abingworth Management, and members of Pharmion's management also participated along with new investors Bay City Capital, New Enterprise Associates, ProQuest Investments, NeoMed Management, Invemed Fund, HealthCap, Merlin BioMed, and Montagu Newhall.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?